Table 2.
no. | metabolites | metabolic pathway | FCc | P-valued | VIPe |
---|---|---|---|---|---|
1 | 5-hydroxytryptaminea | tryptophan metabolism | −23.76 | 7.96 × 10−21 | 3.45 |
2 | LysoPC(14:0) | phospholipid metabolism | −3.58 | 1.78 × 10−18 | 2.71 |
3 | LysoPC(16:1(9Z)) | phospholipid metabolism | −2.65 | 3.77 × 10−18 | 2.60 |
4 | 2-oxobutanoic acid | glutathione metabolism | 3.92 | 4.45 × 10−16 | 1.92 |
5 | fumaratea | tca cycle | −2.30 | 1.24 × 10−15 | 2.51 |
6 | aspartatea | urea cycle | −1.76 | 6.39 × 10−15 | 2.42 |
7 | β-hydroxybutyratea | fatty acid metabolism | 8.59 | 9.87 × 10−15 | 1.63 |
8 | 4-hydroxystyrene | others | −8.44 | 3.05 × 10−14 | 1.63 |
9 | phenylalaninea,b | phenylalanine metabolism | −1.35 | 1.30 × 10−13 | 1.98 |
10 | tetrahydrogestrinone | others | 4.18 | 7.16 × 10−13 | 1.84 |
11 | LysoPC(20:0) | phospholipid metabolism | −2.32 | 1.33 × 10−12 | 2.23 |
12 | glycerola | fatty acid metabolism | 2.61 | 3.14 × 10−12 | 2.22 |
13 | glyceric acida | glucose metabolism | −1.55 | 3.37 × 10−12 | 2.30 |
14 | cis-aconitatea | TCA cycle | −2.60 | 3.37 × 10−12 | 1.57 |
15 | tryptophana,b | tryptophan metabolism | −1.45 | 7.31 × 10−12 | 2.17 |
16 | phenol | tyrosine metabolism | −2.85 | 9.33 × 10−12 | 1.59 |
17 | octenedioate | fatty acid metabolism | 34.75 | 1.37 × 10−11 | 2.40 |
18 | threitola | carbohydrates metabolism | −1.30 | 1.74 × 10−11 | 1.85 |
19 | indoleacrylic acid | gut flora metabolism | −1.44 | 3.55 × 10−11 | 2.21 |
20 | sphinganine | phospholipid metabolism | 4.08 | 6.29 × 10−11 | 1.35 |
21 | 2-hydroxybutyric acida,b | glutathione metabolism | 2.09 | 7.43 × 10−11 | 2.04 |
22 | LPA(18:0/0:0) | others | −1.65 | 1.14 × 10−10 | 2.20 |
23 | indoxyl sulfate | tryptophan metabolism | −2.85 | 3.46 × 10−10 | 1.79 |
24 | histidinea,b | histidine metabolism | −1.28 | 5.82 × 10−9 | 1.91 |
25 | 2-aminobutanoic acida | glutathione metabolism | 1.61 | 1.29 × 10−8 | 1.86 |
26 | alaninea,b | alanine, aspartate, and glutamate metabolism | −1.39 | 1.68 × 10−8 | 1.66 |
27 | 6-phosphogluconic acida,b | pentose phosphate pathway | −1.42 | 6.05 × 10−8 | 1.68 |
28 | ribitol | nucleic acid metabolism | −1.49 | 8.45 × 10−8 | 1.62 |
29 | 4-hydroxyprolinea | proline metabolism | −1.8 | 3.18 × 10−7 | 1.67 |
30 | benzaldehyde | others | −1.38 | 6.12 × 10−7 | 1.33 |
31 | hydroquinonea | tyrosine metabolism | −4.87 | 1.25 × 10−6 | 1.55 |
32 | ureaa | urea cycle | −1.37 | 1.65 × 10−6 | 1.58 |
33 | trihydroxycoprostanoic acid | others | −3.25 | 2.76 × 10−6 | 1.49 |
34 | cholic acida | bile acid metabolism | −4.27 | 2.90 × 10−6 | 1.04 |
35 | LysoPC(P-18:1(9Z)) | phospholipid metabolism | −3.62 | 3.53 × 10−6 | 1.76 |
36 | ubiquinone | oxidative phosphorylation | −1.59 | 4.07 × 10−6 | 1.38 |
37 | 3,4,5-trimethoxycinnamic acid | others | −1.57 | 4.59 × 10−6 | 1.20 |
38 | ornithinea | urea cycle | −1.27 | 5.43 × 10−6 | 1.20 |
39 | indoxyl | tryptophan metabolism | −2.61 | 5.83 × 10−6 | 1.20 |
40 | trimethylamine N-oxidea | choline metabolism | −3.39 | 6.71 × 10−6 | 1.01 |
41 | oleamidea,b | fatty acid metabolism | 2.55 | 7.91 × 10−6 | 1.68 |
42 | oleic acida,b | fatty acid metabolism | 1.55 | 9.31 × 10−6 | 1.58 |
43 | inositol | carbohydrates metabolism | −1.28 | 9.31 × 10−6 | 1.40 |
44 | chenodeoxycholic acida | bile acid metabolism | −3.54 | 1.17 × 10−5 | 1.10 |
45 | serinea | glycine, serine, and threonine metabolism | −1.18 | 1.41 × 10−5 | 1.43 |
46 | methioninea,b | cysteine and methionine metabolism | −1.19 | 1.69 × 10−5 | 1.30 |
47 | asparaginea | alanine, aspartate, and glutamate metabolism | −1.22 | 2.52 × 10−5 | 1.46 |
48 | 2-hydroxy-3-methylpentanoic acid | L-isoleucine metabolism | −8.96 | 3.21 × 10−5 | 1.63 |
49 | erythrotetrofuranose | carbohydrates metabolism | −1.32 | 6.67 × 10−5 | 1.32 |
50 | carnitine (18:1) | fatty acid metabolism | 1.23 | 7.40 × 10−5 | 1.25 |
51 | linolic acida | fatty acid metabolism | 1.43 | 7.56 × 10−5 | 1.34 |
52 | creatininea,b | arginine and proline metabolism | 1.30 | 8.75 × 10−5 | 1.43 |
53 | β-aspartylserine | glycine, serine, and threonine metabolism | −1.81 | 9.12 × 10−5 | 1.20 |
54 | 12a-hydroxy-3-oxocholadienic acid | bile acid metabolism | −2.14 | 1.05 × 10−4 | 1.18 |
55 | CPA(18:0/0:0) | phospholipid metabolism | 2.54 | 1.35 × 10−4 | 1.25 |
56 | acetyl carnitinea | fatty acid metabolism | 1.30 | 1.82 × 10−4 | 1.11 |
57 | allantoic acid | others | −1.20 | 2.05 × 10−4 | 1.07 |
58 | elaidic acida | fatty acid metabolism | 1.42 | 2.97 × 10−4 | 1.33 |
59 | decanoyl carnitine | fatty acid metabolism | −1.39 | 3.88 × 10−4 | 1.01 |
60 | xanthosine | purine nucleotide synthetic | 27.12 | 3.95 × 10−4 | 1.34 |
61 | glutamatea,b | glutathione metabolism | −1.29 | 4.95 × 10−4 | 1.02 |
62 | adeninea | purine nucleotide synthetic | 1.17 | 5.14 × 10−4 | 1.11 |
63 | α-aminoadipic acid | lysine metabolism | −1.93 | 7.70 × 10−4 | 1.20 |
64 | pyruvatea | TCA cycle | 1.30 | 1.10 × 10−3 | 1.15 |
65 | 3-oxodecanoic acid | fatty acid metabolism | 1.37 | 1.53 × 10−3 | 1.09 |
66 | cystinea | cysteine and methionine metabolism | 1.12 | 2.38 × 10−3 | 1.05 |
67 | palmitic acida | fatty acid metabolism | 1.24 | 2.46 × 10−3 | 1.09 |
68 | allyl isothiocyanate | others | 1.15 | 2.85 × 10−3 | 1.10 |
69 | N-acetyl-5-hydroxytryptamine | tryptophan metabolism | −2.49 | 3.87 × 10−3 | 1.01 |
70 | proline betaine | others | 4.46 | 7.96 × 10−3 | 1.30 |
71 | allisoleucine | valine, leucine, and isoleucine degradation | 1.29 | 1.08 × 10−2 | 1.06 |
72 | glycolaldehyde | vitamin B6 metabolism | 2.25 | 2.36 × 10−2 | 1.11 |
Metabolites validated by reference standards.
Metabolites that can be identified by GC–TOFMS and UPLC–QTOFMS.
The fold change (FC) was calculated by the average value of CRC group to that of control group. FC with a value larger than 1.0 indicates a significantly higher level of the serum metabolite in patients while a FC value lower than 1.0 indicates a lower level, compared to healthy controls.
P values were calculated from a nonparametric Mann–Whitney U test.
Variable importance in the projection (VIP) was obtained from OPLS-DA with a threshold of 1.0.